Malignant Progenitors From Patients With Acute Myelogenous Leukemia Are Sensitive to a Diphtheria Toxin–Granulocyte-Macrophage Colony-Stimulating Factor.

Slides:



Advertisements
Similar presentations
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients by Mikkael A. Sekeres, Paul Elson,
Advertisements

Lenalidomide augments actin remodeling and lowers NK- cell activation thresholds by Kathryn Lagrue, Alex Carisey, David J. Morgan, Rajesh Chopra, and Daniel.
Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia by Holly Edwards, Chengzhi Xie,
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples by Keiki Kumano, Shunya Arai, Masataka Hosoi, Kazuki.
Combination therapy for adult T-cell leukemia–xenografted mice: flavopiridol and anti-CD25 monoclonal antibody by Meili Zhang, Zhuo Zhang, Carolyn K. Goldman,
by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E
Dasatinib suppresses in vitro natural killer cell cytotoxicity
Retroviral-Mediated Gene Transduction of c-kit Into Single Hematopoietic Progenitor Cells From Cord Blood Enhances Erythroid Colony Formation and Decreases.
Protein kinase B (PKB/c-akt) regulates homing of hematopoietic progenitors through modulation of their adhesive and migratory properties by Miranda Buitenhuis,
Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia by Thomas Lehrnbecher, Martin Zimmermann,
EBV DNA: a Hodgkin lymphoma biomarker?
Neonatal GATA1 mutant clones under the radar
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology.
by JoAnn Castelli, Elaine K
Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells by Takayuki Ikezoe, Sakae Tanosaki, Utz Krug,
Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis by Shameem Mahmood, Julie Blundell,
Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,
When monocyte life hangs by a thread
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment by Francis Mussai, Carmela De Santo, Issa Abu-Dayyeh, Sarah Booth,
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia by John C. Byrd, Guido Marcucci,
by Gail Dallalio, Erin Law, and Robert T. Means
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in.
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia:
Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood.
DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs or DNA Hypomethylating Agents in MLL-Rearranged.
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
Fertility and Sterility
by Wolfram Springer, Alexander von Ruecker, and Roswitha Dickerhoff
by Rong Chen, Michael J. Keating, Varsha Gandhi, and William Plunkett
Protein Profiling of Hematopoietic Progenitor Cells and Leukemia Cells Identifies Novel Biomarkers Associated with Exposure of Polycyclic Aromatic Hydrocarbons.
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma.
Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations by Oliver Tunstall-Pedoe, Anindita.
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
D3: A Gene Induced During Myeloid Cell Differentiation of Linlo c-Kit+ Sca-1+ Progenitor Cells by Sarah R. Weiler, John M. Gooya, Mariaestela Ortiz, Schickwann.
Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric.
by Jayesh Mehta Blood Volume 112(2): July 15, 2008
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association.
Volume 14, Issue 4, Pages (October 2008)
by Lori A. Styles, Anton J. Aarsman, Elliott P. Vichinsky, and Frans A
Lymphoma spread? Target CD47-SIRPα!
Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide–mediated.
Bifurcated Dendritic Cell Differentiation In Vitro From Murine Lineage Phenotype-Negative c-kit + Bone Marrow Hematopoietic Progenitor Cells by Yi Zhang,
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced.
Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion by Maria C. Kuppner, Anabel Scharner, Valeria.
by Xingwei Sui, Sanford B. Krantz, Min You, and Zhizhuang Zhao
Granulocyte Colony-Stimulating Factor as an Adjunct to Induction Chemotherapy for Adult Acute Lymphoblastic Leukemia — A Randomized Phase-III Study by.
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors by Ugo Testa, Giovanni F.
Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
by Martin S. Tallman, Donna Neuberg, John M. Bennett, Christopher J
by John Anastasi, Rizwan Moinuddin, and Christopher Daugherty
Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens by Jie Yang, Victor M. Lemas, Ian W. Flinn, Chris.
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential by Amy S. Rawls, Alyssa D. Gregory,
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival by Kyu-Tae Kim, Kristin Baird, Joon-Young Ahn, Paul.
Pg and Ec LPS induced levels of soluble mediators from in cultures of individuals with and without T2D with periodontitis. Pg and Ec LPS induced levels.
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.
Unstimulated levels of soluble mediators from in cultures of individuals with and without T2D with periodontitis. Unstimulated levels of soluble mediators.
Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD 
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
VEGF-A concentration is increased in vivo in response to DC101 and in vitro in response to FG VEGF-A concentration is increased in vivo in response.
A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia by Lili Aslostovar, Allison L. Boyd, Mohammed.
Optimal Proliferation of a Hematopoietic Progenitor Cell Line Requires Either Costimulation With Stem Cell Factor or Increase of Receptor Expression That.
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia by Rosemary E. Gale,
Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor Ibrutinib in Patients with Hairy Cell Leukemia: Stage 1 Results of a Phase 2 Study by Jeffrey.
MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor–Dependent Acute Myeloblastic Leukemia Cells by.
by Dana S. Levy, Jason A. Kahana, and Rakesh Kumar
Schematic model illustrating how paracrine signaling drives LPS-stimulated cytokine secretion. Schematic model illustrating how paracrine signaling drives.
Presentation transcript:

Malignant Progenitors From Patients With Acute Myelogenous Leukemia Are Sensitive to a Diphtheria Toxin–Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein by Donna E. Hogge, Cheryl L. Willman, Robert J. Kreitman, Marc Berger, Philip D. Hall, Kenneth J. Kopecky, Chris McLain, Edward P. Tagge, Connie J. Eaves, and Arthur E. Frankel Blood Volume 92(2):589-595 July 15, 1998 ©1998 by American Society of Hematology

Scatchard plot of the blasts of patient no. 1 with 3 Scatchard plot of the blasts of patient no. 1 with 3.36 × 106 cells per aliquot and 125I-GM-CSF specific activity of 84 μCi/μg. Scatchard plot of the blasts of patient no. 1 with 3.36 × 106 cells per aliquot and 125I-GM-CSF specific activity of 84 μCi/μg. The lower 6 concentrations and the higher 4 concentrations were analyzed separately and the r2values on both are .98. Donna E. Hogge et al. Blood 1998;92:589-595 ©1998 by American Society of Hematology

Colony growth inhibition after exposure of cells to DT388-GMCSF in liquid culture for 48 hours followed by their plating in semisolid medium at 17 days (patient no. 34). Colony growth inhibition after exposure of cells to DT388-GMCSF in liquid culture for 48 hours followed by their plating in semisolid medium at 17 days (patient no. 34). Donna E. Hogge et al. Blood 1998;92:589-595 ©1998 by American Society of Hematology